Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Compass Pathways (Group)

COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we are currently conducting a phase IIb clinical trial of psilocybin therapy for TRD, in 20 sites across Europe and North America. We are headquartered in London, UK, with offices in New York, USA. Our vision is a world of mental wellbeing. *


Period Start 2016-06-13 established
  Predecessor Compass Pathways Technologies Ltd.
Product Industry psilocybin therapy
Persons Person Goldsmith, George (Compass Pathways 202004 CEO + Co-Founder)
  Person 2 Wilde, Lars Christian (Compass Pathways 202004 CBO + Co-Founder)
Region Region Altrincham, Greater Manchester
  Country United Kingdom (GB)
  Street 1 Ashley Road
3rd Floor
  City WA14 2DT Altrincham, Cheshire
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: 
Record changed: 2020-09-26


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Compass Pathways (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top